American Journal of Respiratory and Critical Care Medicine

Diseases, Conditions, Syndromes

Relapse-free cure from MDR-TB higher than anticipated

(HealthDay)—The frequency of relapse-free cure from multidrug-resistant tuberculosis (MDR-TB) is higher than previously anticipated, according to a study published in the Aug. 1 issue of the American Journal of Respiratory ...

Health

Chronic vaping exerts biological effects on lungs

(HealthDay)—Chronic vaping exerts biological effects on the lung, some of which may be mediated by the propylene glycol/vegetable glycerin (PG/VG) base, according to a study published in the July 1 issue of the American ...

Diseases, Conditions, Syndromes

Mechanism of fibrosis development discovered

Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease of unknown origin with limited treatment options. Research suggests that the signaling molecule WNT5A plays a key role in the pathogenic process. Now, a group ...

Diseases, Conditions, Syndromes

Use of palliative care, oxygen therapy increasing for COPD

(HealthDay)—For patients with advanced chronic obstructive pulmonary disease (COPD), the use of formal palliative care services and long-term oxygen therapy has increased but remains low, according to a study published ...

Diseases, Conditions, Syndromes

Supplemental antioxidants may reduce exacerbations in cystic fibrosis

An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis (CF), according to new research published online in April in the American Journal of Respiratory and Critical Care Medicine.

page 18 from 40